Skip to Content

WCLC 2023 – NSCLC: New Data on Perioperative Immunotherapy Treatment 

Can perioperative treatment with Imfinzi in combination with chemotherapy improve the pathological complete response (pCR) and increase event-free survival (EFS) in patients with resectable NSCLC with a positive PD-L1 status?

Get access

If you are a doctor, nurse, or other health professionals, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top